Description

T3/T4 Mix by Swiss Healthcare is a pharmaceutical-grade oral formulation that combines two thyroid hormones: Liothyronine Sodium (T3) and Levothyroxine Sodium (T4). This combination mimics the natural ratio of active and storage thyroid hormones in the human body and has been historically studied for its role in metabolic regulation, weight management, and thyroid hormone replacement therapies.

T3 is the more active form, rapidly influencing metabolic rate and energy expenditure, while T4 acts as a prohormone with a slower release, gradually converting into T3 in tissues. This blend is ideal for controlled research into thyroid function, metabolic modulation, and hormonal balance.

Manufactured under strict pharmaceutical conditions, T3/T4 Mix is supplied in bottles containing 60 oral tablets for precise dosing in research settings.

Product Details

• Active Ingredients:

  • Liothyronine Sodium (T3)

  • Levothyroxine Sodium (T4)

• Ratio: Common research ratio: T3 (20 mcg) / T4 (100 mcg) per tablet (adjustable per formulation)

• Form: Oral tablets

• Package Size: 60 tablets per bottle

Pharmacokinetics

T3 has a fast onset with a half-life of ~1 day, providing immediate metabolic effects. T4 has a longer half-life of ~6–7 days, ensuring a sustained release and conversion to T3 over time. Together, they maintain both short-term and long-term thyroid hormone balance in experimental models.

Usage Recommendations

• Typical Research Dosage (historical reference): 1–2 tablets daily, depending on study design

• Current Use: Intended solely for research and laboratory purposes

• Administration: Oral

Disclaimer

This product is intended strictly for research and laboratory use only. It is not approved for human consumption or medical use. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with thyroid or cardiovascular conditions. Always follow applicable laws and laboratory handling protocols.